Pim van der Harst

Prof. Pim van der Harst is a Professor and Scientific Director of the Cardiac Catheterization Laboratory at the Faculty of Medical Sciences, University of Groningen. He is affiliated with the Department of Cardiology and the Cardiovascular Centre (CVC) at UMCG. His clinical expertise includes interventional cardiology, particularly percutaneous treatment of coronary artery disease and acute myocardial infarction. His research focuses on translational medicine, leveraging big data (genetics, EHR, imaging) and machine learning to improve understanding and early detection of cardiovascular diseases such as coronary artery disease and heart failure. He leads large-scale cohort studies like PREVEND and LifeLines, and collaborates globally on projects like EARLY-SYNERGY and CardiOmics (www.cardiomics.net).

His research interests span advanced imaging techniques, device interventions, and eHealth innovations to personalize patient care. Ongoing studies include REPLACE-IT (replacing invasive angiography) and interventional trials like GIPS-IV. He also holds roles as scientific manager of the Durrer Center and on the PREVEND board. His work integrates genomic analysis with clinical outcomes, contributing to polygenic risk scoring and cardiovascular risk stratification.

Recent publications highlight his contributions to cardiac imaging, fibrotic markers in heart failure, and genetic associations with cardiovascular traits. Media coverage includes his work on silent myocardial ischemia detection and blood lipid genetics. He oversees 27 supervised research projects, though specific student names are not listed here.

Key collaborations involve international groups, and his lab (Durrer Center) focuses on translational cardiology. Future work emphasizes AI-driven diagnostics and personalized therapies for cardiovascular diseases.